skip to content
Dovepress - Open Access to Scientific and Medical Research
View our mobile site

8852

HIV reservoirs in vivo and new strategies for possible eradication of HIV from the reservoir sites

Review

(2177) Views  (946) Full article downloads

Authors: Nitin K Saksena, Bin Wang, Li Zhou, et al

Published Date June 2010 Volume 2010:2 Pages 103 - 122
DOI: http://dx.doi.org/10.2147/HIV.S6882

Nitin K Saksena, Bin Wang, Li Zhou, Maly Soedjono, Yung Shwen Ho, Viviane Conceicao

Retroviral Genetics Division, Center for Virus Research, Westmead Millennium Institute, The University of Sydney, Westmead, NSW, Sydney, Australia

Abstract: Even though the treatment of human immunodeficiency virus (HIV)-infected individuals with highly active antiretroviral therapy (HAART) provides a complete control of plasma viremia to below detectable levels (<40 copies/mL plasma), there is an unequal distribution of all antiretroviral drugs across diverse cellular and anatomic compartments in vivo. The main consequence of this is the acquisition of resistance by HIV to all known classes of currently prescribed antiretroviral drugs and the establishment of HIV reservoirs in vivo. HIV has a distinct advantage of surviving in the host via both pre-and postintegration latency. The postintegration latency is caused by inert and metabolically inactive provirus, which cannot be accessed either by the immune system or the therapeutics. This integrated provirus provides HIV with a safe haven in the host where it is incessantly challenged by its immune selection pressure and also by HAART. Thus, the provirus is one of the strategies for viral concealment in the host and the provirus can be rekindled, through unknown stimuli, to create progeny for productive infection of the host. Thus, the reservoir establishment remains the biggest impediment to HIV eradication from the host. This review provides an overview of HIV reservoir sites and discusses both the virtues and problems associated with therapies/strategies targeting these reservoir sites in vivo.

Keywords: HIV, HAART, reservoirs, compartmentalization, elimination strategies for reservoirs, AIDS








Readers of this article also read:

Is it safe? Talking to teens with HIV/AIDS about death and dying: a 3-month evaluation of Family Centered Advance Care (FACE) planning – anxiety, depression, quality of life
Novel mechanisms of central nervous system damage in HIV infection
Effect of HIV infection on time to recovery from an acute manic episode
Human immunodeficiency virus prevalence in an unbooked obstetric population in the Niger Delta
The effect of aging, nutrition, and exercise during HIV infection
Atherosclerosis: pathogenesis and increased occurrence in individuals with HIV and Mycobacterium tuberculosis infection
Antimicrobial therapy for the treatment of opportunistic infections in HIV/AIDS patients: a critical appraisal
Characteristics of foot fractures in HIV-infected patients previously treated with tenofovir versus non-tenofovir-containing highly active antiretroviral therapy
The use of preexposure treatments for HIV prophylaxis
Comparing the World Health Organization- versus China-recommended protocol for first-trimester medical abortion: a retrospective analysis